Introduction
Kidney transplantation is a critical process that guarantees to extend one’s life upon kidney damage. In some instances, the recipient body may reject the new organ, leading to a condition known as acute kidney transplant rejection. This is seen in the case of a 34-year-old Hispanic-American male with end-stage renal disease.
This patient underwent a cadaveric kidney transplant due to the absence of a suitable family donor. His recovery was initially uncomplicated, and he was discharged on immunosuppressive therapy, including tacrolimus, cyclosporine, and azathioprine. After returning to work, he developed weight gain, reduced urine output, fatigue, and fever six months post-transplant and was subsequently diagnosed with acute transplant rejection.
To avoid such incidences, such patients are often given antirejection drugs that work on immunosuppression to ensure the body’s immunity does not fight the organ (Justiz Vaillant et al., 2022). Nevertheless, this does not guarantee the body’s acceptance of the organ and does not translate into specific known symptoms of rejection. Therefore, based on the case of the 34-year-old, this paper analyzes the symptoms he presents and their sources, including the specific genes associated with the condition, how the immunosuppression process arises in such cases, and its overall effect on the body.
Analysis of Symptoms
In this case, the patient presented with decreased urine output, weight gain, and fever. These symptoms indicate acute kidney transplant rejection, often occurring within the first six months after transplantation (Kuan & Schwartz, 2021). In most cases, the transplanted kidney will suffer inflammation and damage following surgery because the body’s immune system will mistake it for a foreign invader. Consequently, urine output decreases because the liver’s filtration function becomes compromised (Kuan & Schwartz, 2021).
Furthermore, the patient’s immune system inflammation and activation lead to fever and fatigue, which, though non-specific, are linked to the rejection considering their timing post-transplantation (Justiz Vaillant et al., 2022). Additionally, despite immunosuppressive drug administration, the patient’s immune system likely overcame the suppression and mounted a response leading to denial. As such, these are the reasons for the patient’s symptoms.
Associated Genes
Nonetheless, various genes are associated with the condition the man has. There is a human leukocyte antigen (HLA) system that, with variations, can compromise the immune system’s ability to recognize and attack foreign tissues, including the transplanted kidney (Dorr et al., 2018). There are also cytokine genes, such as IL-2, IL-6, and TNF-alpha, which can affect how the immune system responds to kidney transplants (Salvadori, 2023). There is also evidence that SDHB, CYC1, UQCRQ, UQCRC1, and SDHA affect rejection (Salvadori, 2023; Soo P, 2018). CYP3A4 and ABCB1 contribute to rejection due to their effects on immunosuppressive drugs (Salvadori, 2023). In this regard, the genes are multiple, with varied effects contributing to the condition.
Immunosuppression and Its Effects on the Body Systems
Immunosuppression is also a critical aspect of this diagnosis and the emerging condition. It refers to dampening the body’s ability to ward off infection. It often arises naturally from a specific condition or deliberately through drug induction, like in the case study (Huaux, 2018). This happens when intracellular pathways are inhibited or immunological effector cells are eliminated.
Despite its benefits, it leads to specific effects such as increased cancer and infection risk. It is also known to have specific adverse effects on the musculoskeletal, digestive, and cardiovascular systems, which can lead to severe conditions such as heart disease and hepatitis, amongst others (Huaux, 2018). In this regard, monitoring it in cases where its benefits are being targeted is critical to manage any adverse effects and prevent complications.
Conclusion
In conclusion, acute transplant rejection is a condition that most individuals who have undergone it have to cope with after the procedure. It translates to symptoms such as increased body weight, decreased urine output, and fever. These symptoms arise from interactions among significant genes such as HLA, IL-2, IL-6, TNF-alpha, SDHB, CYC1, UQCRQ, UQCRC1, SDHA, CYP3A4, and ABCB1. The immunosuppression process can regulate such effects, but it is not always guaranteed. It can lead to increased infection and cancer risk, as well as the malfunctioning of various body systems. Therefore, those who undergo kidney transplantation must be aware of the changes in their bodies post the procedure and have a professional ready to check their vitals regularly.
References
Dorr, C. R., Oetting, W. S., Jacobson, P. A., & Israni, A. K. (2018). Genetics of acute rejection after kidney transplantation. Transplant International, 31(3), 263–277.
Huaux, F. (2018). Emerging role of immunosuppression in diseases induced by micro- and nano-particles: Time to revisit the exclusive inflammatory scenario. Frontiers in Immunology, 9.
Justiz Vaillant, A. A., Vashisht, R., & Zito, P. M. (2022). Immediate hypersensitivity Reactions. StatPearls Publishing.
Kuan, K., & Schwartz, D. (2021). Educational case: Kidney Transplant Rejection. Academic Pathology, 8, 23742895211006832.
Salvadori, M. (2023). Role of biomarkers in detecting acute rejection in kidney transplantation. Transplantology, 4(1), 18–21.
Soo P. (2018). Pathophysiology Ch. 10 alterations in immune function. YouTube.